Kodiak Sciences Inc. (NASDAQ:KOD) is one of the 10 Stocks Investors Dominating the Market Today. Kodiak Sciences soared by 74.77 percent on Thursday to finish at $39.76 apiece, as investors took heart from the strong results of its clinical study for its diabetic retinopathy treatment. In an updated report, Kodiak Sciences Inc. (NASDAQ:KOD) said that 62.5 percent of the enrolled patients in the GLOW clinical trial achieved a more than 2-step improvement in diabetic retinopathy severity score for those wh ...